Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
3(33%)

Phase Distribution

Ph not_applicable
9
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
N/ANon-phased studies
9(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
62.5%
Most Advanced
N/A

Trials by Phase

N/A9 (100.0%)

Trials by Status

terminated333%
unknown111%
completed556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9